| 1 | [SID22414554] | Active | Potency | 0.5623 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 2 | [SID22414554] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 3 | [SID22414554] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 4 | [SID22414554] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 5 | [SID22414554] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 6 | [SID22414554] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 7 | [SID22414554] | Active | IC50 | 3.94892 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | IC50 | 3.94892 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 8 | [SID22414554] | Active | IC50 | 3.94892 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | IC50 | 3.94892 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 9 | [SID22414554] | Active | IC50 | 3.94892 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | IC50 | 3.94892 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 10 | [SID22414554] | Active | AC50 | 7.153 | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) [AID449757, Type: confirmatory] | Bcl-2-like protein 11 [gi:18202042] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | AC50 | 7.153 [uM] | | BioAssay | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) | | AID | 449757 | | BioAssay type | confirmatory | | Target | Bcl-2-like protein 11 [gi:18202042] | | PubMed | | | Data Table |  |
|
| 11 | [SID22414554] | Active | AC50 | 7.153 | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) [AID449757, Type: confirmatory] | Bcl-2-like protein 11 [gi:18202042] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | AC50 | 7.153 [uM] | | BioAssay | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) | | AID | 449757 | | BioAssay type | confirmatory | | Target | Bcl-2-like protein 11 [gi:18202042] | | PubMed | | | Data Table |  |
|
| 12 | [SID22414554] | Active | AC50 | 7.153 | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) [AID449757, Type: confirmatory] | Bcl-2-like protein 11 [gi:18202042] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | AC50 | 7.153 [uM] | | BioAssay | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) | | AID | 449757 | | BioAssay type | confirmatory | | Target | Bcl-2-like protein 11 [gi:18202042] | | PubMed | | | Data Table |  |
|
| 13 | [SID22414554] | Active | AC50 | 7.153 | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) [AID449757, Type: confirmatory] | Bcl-2-like protein 11 [gi:18202042] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | AC50 | 7.153 [uM] | | BioAssay | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) | | AID | 449757 | | BioAssay type | confirmatory | | Target | Bcl-2-like protein 11 [gi:18202042] | | PubMed | | | Data Table |  |
|
| 14 | [SID22414554] | Active | EC50 | 8.156 | Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis [AID2765, Type: confirmatory] | bcl-2-like protein 11 isoform 1 [Homo sapiens] [gi:20336315] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | EC50 | 8.156 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis | | AID | 2765 | | BioAssay type | confirmatory | | Target | bcl-2-like protein 11 isoform 1 [Homo sapiens] [gi:20336315] | | PubMed | | | Data Table |  |
|
| 15 | [SID22414554] | Active | EC50 | 8.156 | Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis [AID2765, Type: confirmatory] | bcl-2-like protein 11 isoform 1 [Homo sapiens] [gi:20336315] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | EC50 | 8.156 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis | | AID | 2765 | | BioAssay type | confirmatory | | Target | bcl-2-like protein 11 isoform 1 [Homo sapiens] [gi:20336315] | | PubMed | | | Data Table |  |
|
| 16 | [SID22414554] | Active | EC50 | 8.156 | Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis [AID2765, Type: confirmatory] | bcl-2-like protein 11 isoform 1 [Homo sapiens] [gi:20336315] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | EC50 | 8.156 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis | | AID | 2765 | | BioAssay type | confirmatory | | Target | bcl-2-like protein 11 isoform 1 [Homo sapiens] [gi:20336315] | | PubMed | | | Data Table |  |
|
| 17 | [SID22414554] | Active | EC50 | 8.156 | Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis [AID2765, Type: confirmatory] | bcl-2-like protein 11 isoform 1 [Homo sapiens] [gi:20336315] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | EC50 | 8.156 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis | | AID | 2765 | | BioAssay type | confirmatory | | Target | bcl-2-like protein 11 isoform 1 [Homo sapiens] [gi:20336315] | | PubMed | | | Data Table |  |
|
| 18 | [SID22414554] | Active | AC50 | 12.96 | Luminescence Cell-Based Counterscreen to Identify Inhibitors of A1 Apoptosis (Bax-Bak knockout) [AID449754, Type: confirmatory] | Chain A, Human Bcl2-A1 In Complex With Bim-Bh3 Peptide [gi:167013344] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | AC50 | 12.96 [uM] | | BioAssay | Luminescence Cell-Based Counterscreen to Identify Inhibitors of A1 Apoptosis (Bax-Bak knockout) | | AID | 449754 | | BioAssay type | confirmatory | | Target | Chain A, Human Bcl2-A1 In Complex With Bim-Bh3 Peptide [gi:167013344] | | PubMed | | | Data Table |  |
|
| 19 | [SID22414554] | Active | Potency | 14.6892 | qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21 [AID2289, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 14.6892 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21 | | AID | 2289 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID22414554] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID22414554] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID22414554] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 23 | [SID22414554] | Active | AC50 | 20.77 | Luminescence Cell-Based Counterscreen to Identify Inhibitors of A1 Apoptosis (non-primed) [AID449761, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | AC50 | 20.77 [uM] | | BioAssay | Luminescence Cell-Based Counterscreen to Identify Inhibitors of A1 Apoptosis (non-primed) | | AID | 449761 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID22414554] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 25 | [SID22414554] | Active | AC50 | 26.33 | Luminescence Cell-Based Counterscreen to Identify Inhibitors of A1 Apoptosis (HMC 1-8 low) [AID449755, Type: confirmatory] | Chain A, Human Bcl2-A1 In Complex With Bim-Bh3 Peptide [gi:167013344] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | AC50 | 26.33 [uM] | | BioAssay | Luminescence Cell-Based Counterscreen to Identify Inhibitors of A1 Apoptosis (HMC 1-8 low) | | AID | 449755 | | BioAssay type | confirmatory | | Target | Chain A, Human Bcl2-A1 In Complex With Bim-Bh3 Peptide [gi:167013344] | | PubMed | | | Data Table |  |
|
| 26 | [SID22414554] | Active | Potency | 31.6228 | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 27 | [SID22414554] | Active | Potency | 31.6228 | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 28 | [SID22414554] | Active | Potency | 50.1187 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 29 | [SID22414554] | Active | Potency | 50.1187 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 30 | [SID22414554] | Active | Potency | 50.1187 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 31 | [SID22414554] | Active | Potency | 50.1187 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 32 | [SID22414554] | Active | IC90 | 100 | Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics [AID434955, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | IC90 | 100 [uM] | | BioAssay | Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics | | AID | 434955 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID22414554] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID22414554] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 35 | [SID22414554] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 36 | [SID22414554] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 37 | [SID22414554] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 38 | [SID22414554] | Active | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 39 | [SID22414554] | Active | | | Primary screen for compounds that activate Alzheimer's amyloid precursor [AID1276, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Primary screen for compounds that activate Alzheimer's amyloid precursor | | AID | 1276 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 40 | [SID22414554] | Active | | | Primary screen for compounds that activate Alzheimer's amyloid precursor [AID1276, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Primary screen for compounds that activate Alzheimer's amyloid precursor | | AID | 1276 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 41 | [SID22414554] | Active | | | Primary screen for compounds that activate Alzheimer's amyloid precursor [AID1276, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Primary screen for compounds that activate Alzheimer's amyloid precursor | | AID | 1276 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 42 | [SID22414554] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 43 | [SID22414554] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 44 | [SID22414554] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 45 | [SID22414554] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 46 | [SID22414554] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 47 | [SID22414554] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) [AID588814, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) | | AID | 588814 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 48 | [SID22414554] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) [AID588814, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) | | AID | 588814 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 49 | [SID22414554] | Active | | | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen [AID1239, Type: screening] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen | | AID | 1239 | | BioAssay type | screening | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|
| 50 | [SID22414554] | Active | | | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen [AID1239, Type: screening] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22414554 | | CID | 1047727 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen | | AID | 1239 | | BioAssay type | screening | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|